12:00 AM
 | 
Jan 14, 2013
 |  BC Week In Review  |  Company News  |  Other News

Amakem, Flemish Agency for Innovation by Science and Technology autoimmune news

Amakem received an €1.4 million ($1.8 million) grant from the agency to use Amakem's localized drug action technology to discover and develop kinase inhibitor-based therapies to...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >